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ABSTRACT  We  are  investigating the  hypothesis that carbohydrate-binding  molecules  on  the 
cell  surface  are  involved  in  the  recirculation  of  lymphocytes  from  the  bloodstream  into 
lymphoid organs. This phenomenon requires the specific attachment of circulating lymphocytes 
to the endothelial cells of postcapillary venules.  Using an in vitro assay to measure the adhesive 
interaction between lymphocytes and  postcapillary venules, we have found that L-fucose, D- 
mannose,  and  the  L-fucose-rich,  sulfated  polysaccharide  fucoidin  specifically  inhibit  this 
binding interaction.  L-fucose  shows stereo-selective  inhibitory activity at concentrations >18 
mM  while fucoidin  produces 50% inhibition at ~1-5 x  10 -0 M. Fucoidin appears to interact 
with the lymphocyte, and not the postcapillary venule, to inhibit binding. These data suggest 
that cell  surface carbohydrates (fucoselike)  and carbohydrate-binding molecules  (cell  surface 
lectins)  may contribute to the specific attachment of lymphocytes to postcapillary venules. 
Normal lymphocytes circulate repeatedly through the blood- 
stream, tissues and lymphatic system (1, 2). This phenomenon 
has been termed "recirculation" and is thought to be critical to 
the normal function of the immune system, perhaps ensuring 
the widest possible distribution and exposure to antigen of an 
individual's  repertoire  of lymphocyte clones.  The  portal  of 
entry for bloodstream lymphocytes into tissues appears to be 
the postcapillary venules. In rodents and humans, the postcap- 
iUary venules  of lymph nodes  and  Peyer's patches  have  an 
unusual histologic appearance characterized by a single layer 
of prominent, cuboidal endothelial cells resting on a basement 
membrane (termed high endothelial venules, HEV). 
Histologic studies have documented an intimate association 
of intravascular lymphocytes with HEV (2-4). Electron micro- 
scopic studies suggest that circulating lymphocytes first attach 
to the luminal surfaces of HEV, then pass through their inter- 
endothelial junctions and basement membrane  into the sur- 
rounding nodal parenchyma (4).  Thus, the first step in lym- 
phocyte recirculation is the attachment of blood-borne cells to 
specialized postcapillary venules. 
A  more  detailed  examination  of this  adhesive  interaction 
was made possible  by the development of an in vitro  assay 
using  lymphocyte  suspensions  and  frozen  tissue  sections. 
Stamper and Woodruff, and Butcher et al. were able to show 
that  fresh lymphocytes bound avidly and  specifically to the 
HEV of either glutaraldehyde-tLxed (5,  6) or air-dried  (7,  8) 
frozen sections  of lymph nodes.  This binding was  found to 
correlate with the flux of blood-borne lymphocytes into lymph 
nodes in vivo. For example, thymocytes, which have a dimin- 
ished capacity to enter peripheral lymphoid organs when com- 
pared to cells derived from spleen, lymph nodes, or peripheral 
blood,  show correspondingly less  binding to HEV in frozen 
sections  (5,  7).  The  most  convincing  demonstration  of the 
correlation between attachment to HEV in vitro and entry into 
lymph nodes in vivo is in the work of Butcher et al. (8). These 
investigators quantified the binding of lymphocytes from dif- 
ferent species to the HEV of mouse lymph nodes in vitro, and 
compared  this  measurement  to  the  flux  of these  cells  into 
lymph nodes in vivo. The binding in vitro and the flux in vivo 
diminished in parallel as the evolutionary distance between the 
mouse and the source of the lymphocytes increased. These data 
suggest  that  the  binding  of lymphocytes to  HEV  in  frozen 
sections reflects a physiologically significant adhesive interac- 
tion. 
We  have  employed  a  modification  of the  in  vitro  assay 
described above to study the nature of the adhesive molecules 
on the  surface  of lymphocytes and  HEV.  In this  study  we 
report  evidence  suggesting that  carbobydrate-binding  mole- 
cules on the cell surface participate in this interaction. 
MATERIALS  AND  METHODS 
Chemicals:  Monosaccharides were obtained from Sigma Chemical Co. 
(St. Louis, MO). Fucoidin was purchased from K & K  Labs, Plainview, NY and 
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droitin sulfate (C3254), dextran sulfate (D7515),  hyaluronic acid (H175 I), der- 
matan sulfate (C4259),  thyroglobulin (T1126),  horseradish peroxidase (P8250), 
invertase (14753), glycogen (G9251), mannan (M7504),  and bovine serum albu- 
min (A4378) were obtained from Sigma Chemical Co. Heparan sulfate was a 
kind gift of Dr. A. Linker (Veterans Administration Hospital, Salt Lake City, 
UT). 
Preparation  of  Frozen  Sections:  Superficial or  deep  cervical 
lymph nodes were dissected from ether-anesthetized rats (Spragne-Dawley, 180- 
200 g, obtained from Simonsen Laboratories, Gilroy, CA), snap frozen at -160°C 
(in 2-methyl-butane cooled in liquid nitrogen), and  immediately placed in a 
cryostat for sectioning (IEC Cryostat at -20°C).  10-/Lm sections were prepared 
and  transferred  onto glass slides (Clay Adams  Laboratory  Systems #A1460, 
Becton-Dicklnson & Co., Rutherford, N J; or Carlson Scientific Inc., Petone, IL; 
#00301) kept at room temperature. Sections must be relatively  free of corregations 
and defects for optimal results. We found that moving the tissue sections from 
the cutting edge to a  highly polished, flat portion of the blade before transfer 
onto the glass slide increased the yield of such sections. Sections were dried onto 
the sides at room temperature for I-3 h, then stored at 4°C until use (in tightly 
closed slide boxes).  Sections  prepared  and  stored  in this fashion maintained 
binding activity for  1-2  wk (storage at  room temperature resulted in loss of 
activity usually within 2-3  d).  Before  use,  the  slides were  warmed  to  room 
temperature in a  dessicator (to minimize the formation of condensation on the 
tissue section). Once removed from 4°C storage, sections were used within 3 h. 
Binding Assay:  We adapted our method from that of Butcher et al. (6, 
7). Lympliocytes were teased from the superficial and deep cervical lymph nodes 
of two to four  Sprague-Dawley rats (8 wk old,  180-200 g), and suspended in 
buffer at 4°C (Hanks" balanced salt solution containing 1 mg/ml of bovine serum 
albumin (BSA), pH 7.4,  or minimal essential medium in Earle's salts (without 
sodium bicarbonate) containing 1 mg/ml BSA and buffered with 40 mM Tricine, 
pH 7.4). Both the Hanks' balanced salts buffer (HBS+) and the Earle's minimal 
essential medium  (MEM+)  were isotonic and  isoionic relative to  normal rat 
serum (9). The ceils were dispersed by rapid, in-out pipetting (~ 100 cycles), and 
the cell clumps removed by passage through several layers of cheese cloth. The 
resultant single cell suspension was washed two to three times in 30-ml aliquots 
of buffer, suspended at a final concentration of 4 x  107 cells/m1, and kept on ice 
until use.  Cell  suspensions prepared  in  this  manner  were  relatively free  of 
phagocytic cells (<10% as judged by latex particle ingestion) and were -80% 
viable by trypan blue exclusion. 
Potential inhibitors were added to lymphocyte suspensions (1-2 x  107 cells/ 
ml at 4°C) 10-30 min before the start of the binding assay and, unless otherwise 
stated, were present throughout the subsequent binding incubation. The binding 
incubations were conducted on glass slides in 1.4 or 2 cm diameter wax or epoxy 
circles (wax circles were drawn onto slides at room temperature immediately 
before the start of a  binding assay; premade slides, with 1.4-cm  diameter holes 
cut into a thin epoxy film, were obtained from Carlson Scientific Inc.). 
The frozen sections were used in the order in which they were cut. Aliquots of 
untreated lymphocytes (controls) and suspensions containing potential inhibitors 
were layered on the sections in an arbitrary sequence such that the control and 
each test substance were represented once in a  series. The series was repeated 
until the desired number of replicates had been generated. This procedure was 
designed to minimize bias arising from the possible heterogeneity in the binding 
characteristics of HEV from different regions of the lymph node. In view of the 
marked quantitative difference in binding that we and others (6) have observed 
from one lymph node to the next, only sections prepared from a single node were 
used in any one experiment. 
The assay was initiated by layering the 4°C cell suspensions onto the sections 
(at room temperature). The slides were then placed on a metal tray, supported on 
packed ice, and agitated on  a  gyratory shaker at  80 or  100 rpm (G-24,  New 
Brunswick Scientific Co., Inc., Edison, N J; %-in radius of gyration). The temper- 
ature of the slides equilibrated at 7-10°C. After a  50-rain incubation, the ceil 
suspensions were decanted and the sections fixed in 3% glutaraldehyde (20 rain 
at 4°C). The slides were then placed in racks, washed in Dulbecco's phosphate- 
buffered saline (five, one-second immersions), stained with @5% toluidine-blue 
in a 20% ethanol solution (one,  15-60 second immersion), washed in 95% EtOH 
(one, two-second immersion), and mounted in glycerol. Sections processed in this 
manner were stored at 4°C until analyzed. 
General Characteristics and Quantitation of Lymphocyte 
Binding in Vitro:  In the absence of inhibitors, lymphocytes attach, pri- 
marily, to the HEV and to the glass surrounding the tissue section on the slide. 
Lymphocytes also adhere to the nodal parenchyma away from the HEV; however, 
the density of binding is at least 50-fold greater at the HEV than at these other 
sites. The binding to the HEV was easily distinguished from binding elsewhere 
by virtue of the characteristic picture of tightly packed, darkly stained lympho- 
cytes overlying  the histologically  distinctive  HEV (Fig. 1  ). Lymphocytes overlying 
non-HEV sites do not show the same degree of organization and specificity-- 
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FIGURE  1  View of lymphocyte-HEY binding interaction. A, luminal 
surface  of  HEV.  B, cuboidal  endothelial cells.  C,  lymphocytes ad- 
hering to various endothelial cell surfaces and, possibly, the extra- 
cellular matrix. D, diffuse  (para-) cortex of the lymph node.  E and 
F, binding to HEV sectioned tangentially. Bar, 45 #m. x  225. 
they are spaced farther apart and generally do not adhere to specific cell types 
(lymphocytes versus phagocytes) or anatomic structures (germinal centers versus 
medullary cords or large vessels). In a small percentage of experiments (10-20%), 
exogenous lymphocytes adhered selectively to sinusoidal cells as well as to the 
HEV.  This  binding interaction was  most  pronounced  in  lymph  nodes  with 
prominent, cellular sinnsoids. Our preliminary results (data not shown) indicate 
that,  unlike binding at  HEV,  binding to  sinusoids cannot be  inhibited with 
fucoidin. Only those sections in which binding to HEV could be readily distin- 
guished from binding at non-HEV sites were used in our studies. 
All experiments were initially  examined blindly. The experiments depicted in 
Figs. 3-6 were quantified in a single-blind fashion. The binding of lymphocytes 
to HEV was assessed by examining the cortices of the lymph node sections and 
calculating the average number of lymphocytes attached to HEV in either low 
power (x 200) or high power (x 400) microscopic fields (HEV-bound lympho- 
cytes per field). Specifically, contiguous fields were surveyed until the  entire 
surface of the node had been examined. The number of lymphocytes attached to 
HEV was determined in a  representative sample of the cortical fields (ranging 
from every field to every third field). We adjusted the sample size (number of 
fields counted) so that at least 200 lymphocytes were scored on each section (if 
fewer than 200 ceils were bound to an entire frozen section, then all cortical fields 
were counted). Individual data points represent the mean and standard error of 
the mean (SEM) for measurements on three to five separate frozen sections taken 
from various regions of the lymph node (see Binding Assay). When calculated in 
this fashion, SEMs for individual data points ranged from 15% to 40%. 
In one experiment (Fig. 9), binding was quantified by determining the average 
number of lymphocytes bound per HEV (cells bound per HEV). The sampling 
procedure  was  identical to  that described  above,  except that  the  number of 
discrete  HEV  (regardless of  their  size),  as  well as  the  number  of  attached 
lymphocytes,  was  determined.  At  least 200  lymphocytes and  40  HEV  were 
counted on each section. 
In the absence of inhibitors, 0.5-5% of the added lymphocytes adhere to the 
HEV. This percentage varied from node to node but stayed relatively constant 
from section to section within any one lymph node. As noted previously, other 
investigators have  observed  a  similar intemodal  variation in  binding.  This 
phenomenon may reflect, in part, fluctuations in the cross-sectional area of HEV 
from one node to the next. We have also noted that the density of binding at the 
HEV, i.e., the number of lymphocytes attached per/tin  2, also varied considerably 
(data not shown). This measure is independent of the actual number or area of 
HEV available in any particular frozen section; therefore, this finding suggests 
that the adhesive bond between lymphocytes and HEV may fluctuate in strength 
from one lymph node to the next. We used lymph nodes that vary markedly in 
the nature and degree of their recent immunologic activity. If antigenic stimula- 
tion alters the strength of the  HEV-lymphocyte binding interaction, then the 
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immunologic histories of the lymph nodes and lymphocyte suspensions used in 
different experiments. This apparent variation in the strength of the lymphocyte- 
HEV binding interaction did not affect  our data since individual experiments 
were carried out using sections from a single  node and single  pools of freshly 
prepared lymphocytes. 
Protein Synthesis:  The rate of protein synthesis in lymphocytes was 
determined by measuring the incorporation of [aH]leucine (ICN Pharmaceuticals, 
Inc.,  h'vine,  CA;  Cat.  #20032,  120  Ci/mM)  into  TCA-precipitable  counts. 
Lymphocytes prepared as described above were suspended at 5 ×  106 cells per ml 
in ieueine-free  buffer containing penicillin  and streptomycin (100 U/m1 and 100 
t~g/ml, respectively).  Incubations were begun by adding 1 ~Ci of [aH]leucine to 
l-m1 aliquots of cells containing the various test substances. After varying periods 
of incubation at 37°C, the reactions were stopped with cold trichloroacetic acid 
(final concentration of 10%) and the precipitates were coUected by filtration onto 
GFC filters (Whatman Inc., Paper Die., Clifton, N J). The filters were washed in 
TCA and absolute ethanol, added to scintillation  vials with 10 ml of Hydrofluor 
(National Diagnostics, Inc., Advanced Applications Institute Inc.,  SomerviUe, 
N J), and counted. Nonspecific binding was determined by using  zero-time blanks. 
The rate of [aH]leucine  incorporation was found to be linear over at least  2 h. 
Levels of incorporation were compared after 90 rain of incubation (the approxi- 
mate time of exposure of lymphocytes to the inliibitors  in the binding assays). 
RESULTS 
Effect of Monosaccharides 
We examined the effects of a series of neutral monosaccha- 
rides on lymphocyte attachment to HEV in vitro (Fig. 2). This 
panel included sugars that are commonly found in cell surface 
glycoconjugates and that are known ligands  for endogenous 
mammalian lectins  (10).  At a  concentration of 150 mM,  D- 
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FIGURE  2  Lymphocyte attachment in the presence of monosaccha- 
rides  (150  raM).  0.2  ml  of  lymphocyte  suspensions,  containing 
various test substances, were incubated over sections in 2-cm circles 
and gyrated at 80 rpm  as specified  in  Materials and  Methods  (7- 
10°C; I-2 x  107 cells/ml in HBS+). CONT. (no-added-sugar control); 
L-FUC (t-fucose); D-FUC (D-fucose); MANN (D-mannose); NAcGLu 
(N-acetyl-D-glucosamine);  D-GAL  (D-galactose),  RELATIVE  BIND- 
ING =  Binding in presence of inhibitor +  binding in control x  100. 
Data pooled from multiple independent experiments, total number 
of replicates (frozen sections)--control  (15), L- and D-Fucose (19), 
o-mannose (11), N-acetyl-D-glucosamine (8), D-galactose (10).  Dif- 
ferences between L-fucose and D-fucose, D-mannose and D-fucose 
statistically significant  (by t test) with probabilities less than 0.0005 
and 0.005  respectively. D-glucose  (data not shown)  produced  no 
significant inhibition relative to D-fucose. 
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fucose, D-glucose, D-galactose, and N-acetyl-D-glucosamine en- 
hanced  lymphocyte binding  relative  to  the  no-added-sugar 
control, whereas L-fucose and D-mannose had no significant 
effect. However, lymphocyte attachment in the presence of L- 
fUCOSe and D-mannose was 50% lower than that in the presence 
of the other sugars examined. 
The mechanism underlying the enhancement of lymphocyte 
binding to HEV in the presence of a  variety of structurally 
dissimilar monosaccharides is unknown. The effect appeared 
to be relatively selective since neither the nonspecific binding 
of lymphocytes to tissue sections away from the HEV, nor the 
adhesion  of lymphocytes to  one  another  in  suspension  in- 
creased under these conditions. It is conceivable that alterations 
in  the  membrane  structure  of either  the  lymphocyte or the 
HEV  may  be  involved.  Scanning  electron  micrographs  of 
lymphocytes in  suspension  have  shown  an  increase  in  the 
number and prominence of membrane microviUi in hypertonic 
solutions  (11).  Since  circulating  lymphocytes anchor to  the 
HEV at the tips of their microviUi (4), one might expect that 
changes induced in these structures by hypertonic sugar solu- 
tions might enhance lymphocyte binding in vitro. Regardless 
of the mechanism, this enhancement suggested that the most 
appropriate  control  for judging the  inhibitory  potency of a 
particular  sugar  was  an  equimolar  concentration  of other 
sugars. When viewed in this manner, L-fucose and D-mannose 
appeared to produce a significant depression in the affinity of 
lymphoeytes for HEV. 
In an effort to enhance the suspected inhibitory activities of 
the simple sugars, we examined the effect of high ionic strength 
buffers on the attachment of lymphocytes to HEV. Fig. 3 shows 
that increasing the ionic strength of the incubation buffer, by 
adding NaCI, results in a  dose-dependent  reduction in lym- 
phocyte binding. A  40% increase in ionic strength relative to 
120 
100 
z 
z  80 
I,LI 
>-  60  l- 
ID 
""  40 
20 
±  I 
i 
0  I  I  I  i  t  ,  ~  I  I  I 
0  20  40  60  80  100 
NaCI  (nM) 
FIGURE  3  Lymphocyte attachment in the presence of NaCI. 0.12 ml 
of the lymphocyte suspensions, containing various test substances, 
were incubated over sections in 1.4-cm diameter circles and gyrated 
at 80 rpm as specified  in Materials and Methods  (7-10°C; 2 x  107 
ceils/ml  in  MEM+).  RELATIVE  BINDING  (ordinate)  =  (binding  in 
presence of NaCI)  +  (binding in control)  x  100. Means and SEMs 
based  on  four  replicates.  Degree  of  inhibition  by  NaCI  varied 
between experiments and may reflect heterogeneity in the strength 
of  the  binding interaction with  different  lymphocyte suspensions 
and lymph nodes. The difference between the control  (no-added- 
salt)  and 60 mM  added  NaCl  is  statistically significant  (by t  test) 
with a probability of <0.025. CI 
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FIGURE  4  Lymphocyte at- 
tachment  in  the  presence 
of L- or O-fucose (150 raM) 
with  and  without  added 
NaCI  (60  mM).  Additional 
incubation  conditions  as 
specified  in  legend of  Fig. 
3.  Clear  bar,  no  added 
sugar; stipled bar, t-fucose; 
cross-hatched  bar,  D-fu- 
cose.  Ordinant  =  HEV 
bound  cells/LOW  power 
cortical  field.  Means  and 
SEM  based on three repli- 
cates. The following differ- 
ences  (in  the  presence of 
60  mM  added  NaCI)  are 
statistically  significant  (by 
t test): Control vs. L-fucose, 
(p <  0.0005); control vs. D- 
fucose, (p <  0.05);  L-fucose 
vs. D-fucose, (p <  0.005). 
normal rat serum (produced by adding 60 mM NaC1) resulted 
in a  60%  decrease in lymphocyte attachment  to HEV.  Ionic 
strength  rather  than  osmolarity  appeared  to  be  the  critical 
factor in reducing adhesiveness,  since hypertonlc solutions of 
D-fucose, o-galactose, and GIcNAc (in which ionic strengths 
were unchanged) enhanced rather than inhibited lymphocyte 
attachment (Fig. 2). 
Fig.  4  demonstrates  the  effect of increased  ionic strength 
(permissive conditions) on the inhibitory potencies of D- and 
L-fucose. In this experiment, 60 mM additional NaCI depressed 
lymphocyte attachment  twofold relative  to the control (con- 
taining neither added salt nor sugar). The addition of 150 mM 
L-fucose resulted  in  a  further  six-  to  eightfold  reduction  in 
binding,  while  an equal concentration of D-fucose enhanced 
rather than inhibited attachment relative to the control (con- 
taining salt but no added sugar).  Thus, increasing the NaCI 
concentration of the  incubation  medium,  such that  its  ionic 
strength  exceeded  that  of normal  rat  serum  by  40%,  both 
weakened the adhesive bond between lymphocytes and HEV 
and enhanced the inhibitory potency of L-fucose. 
The dose-response curves for L- and D-fucose under permis- 
sive conditions are shown in Fig. 5. Relative to the no-added- 
sugar control (Fig. 5 a), D-fucose produced a dose-dependent 
increase  in lymphocyte attachment  that plateaued  at  a  level 
50% above the control (p <  0.05  at 37 mM).  In contrast, r- 
fucose caused little if any increase in lymphocyte attachment 
at low concentrations followed by a  significant inhibition in 
binding at concentrations of 75 and 150 mM (p <  0.05). When 
compared to equal concentrations of D-fucose, L-fucose pro- 
duced significant inhibition at concentrations of 18 mM (see 
figure legend for p  values)  and  above (Fig.  5 b).  o-mannose 
also  produced  dose-dependent  inhibition  but  was  approxi- 
mately twofold less potent than L-fucose. Thus, increasing the 
ionic strength of the incubation medium with NaCI enhanced 
the potency of L-fucose relative to both no-added-sugar con- 
trois and controls containing equal concentrations of D-fucose. 
In light of NaCl's synergistic affect on inhibitory monosac- 
charides,  we re-examined the behavior of a  series of neutral 
sugars in high salt (Fig. 6). At a concentration of 150 mM, only 
L-fucose,  D-man_nose,  and  a-methyl-o-mannoside  depressed 
lymphocyte attachment relative to the no-added-sugar control. 
D-galactose,  N-acetyl-D-glucosamine,  L-rhamnose,  D-fucose, 
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D-glucose, D-ribose, and N-acetyl-D-galactosamine either en- 
hanced  binding  or had  no  significant  effect  relative  to  the 
control. 
We were concerned that inhibition under "permissive" con- 
ditions might be due to the selective agglutination of lympho- 
cytes in the presence of inhibitory monosaccharides. Therefore, 
we estimated the degree of agglutination by fixing lymphocytes 
remaining in suspension after a binding assay (with glutaral- 
dehyde)  and  determining  the  number  of single  cells.  The 
number of single cells depends  on both the number of cells 
forming aggregates and the number of cells that attach to the 
glass or the tissue section. Since the majority of added lympho- 
cytes  remain  in  suspension  at  the  end  of a  binding  assay 
(>80%),  the number of singles should reflect,  primarily,  the 
degree of cell agglutination.  We found that L-fucose did not 
produce a  significant decrease  in the number of single cells 
when compared to a  no-added-sugar control, D-galactose, or 
D-fucose. We obtained identical results when lymphocyte ag- 
glntination  was  assessed  under  the  same  conditions  in  the 
absence of tissue sections. Thus, cellular agglutination does not 
appear to be a factor in the inhibition of binding produced by 
specific monosaceharides. 
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FIGURE  5  Dose-response curves  for  D-  and  L-fucose  with  added 
NaCI (60 mM). Additional incubation conditions as specified in the 
legend  of  Fig. 3.  Means  and  SEMs based  on  four  replicates.  (a) 
Binding relative to no-added-sugar control. Relative binding (ordi- 
nate)  =  (binding  in  the  presence of  fucose)  +  (binding  in  the 
control)  x  100. D-fucose, solid line; L-fucose,  dashed line. (b)  Inhi- 
bition of L-fucose regative  to D-fucose.  RELATIVE BINDING  (ordi- 
nate)  =  (binding  in  the  presence of  L-fucose)  +  (binding  in  the 
presence of D-fucose)  X 100. 
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RGURE  6  Lymphocyte attachment in the presence of a  variety of 
monosaccharides (150 raM) with additional 60 mM NaCI  ("permis- 
sive" condition). Additional incubation conditions as specified in 
the  legend  of  Fig. 3.  Ordinant  --  HEV  bound  cells/lOW  power 
cortical  field. Means and SEMs based on four replicates. N-aceWI- 
D-galactosamine, L-rhamnose, and D-ribose (data not shown) pro- 
duced no inhibition relative to the control. Degree of accentuation 
by o-fucose varied  between experiments and  may reflect hetero- 
geneiW in strength of binding interaction with different lymphocyte 
suspensions and lymph nodes. 
In light of the known inhibitory effect of i)-maunose on cell 
division (12) and L-fucose on cell division and DNA synthesis 
(13)  in cultured  ceils, we examined  rat lymphocytes for evi- 
dence of sugar-induced toxicity under "permissive" conditions. 
Pre-  and  post-assay  measurements  showed  75-80%  of cells 
capable of excluding trypan blue regardless of the nature  of 
the added sugar. Furthermore, the rate of protein synthesis, as 
judged by [aH]leucine incorporation, was depressed to the same 
degree  by  all  sugars  whether  they  inhibited  binding  or not 
(Table IA). Therefore, L-fucose and D-mannose do not appear 
to be selectively toxic for lymphocytes in  short-term experi- 
ments. 
The reason for the generally reduced synthetic activity under 
"permissive" conditions, with or without the various monosac- 
charides, is not known. However, the fact that equal concen- 
trations  of structurally  diverse  monosaccharides  resulted  in 
equivalent  degrees  of inhibition  suggests  that  hypertonicity 
may have had a nonspecific effect on lymphocyte metabolism. 
Such a phenomenon has been described in other cells (14). 
Effect of Glycoconjugates 
Our sugar inhibition results suggested that a carbohydrate- 
binding molecule, with fucose/mannose specificity, might be 
involved in the adhesive interaction between lymphocytes and 
HEV.  Frequently,  the  affinity of lectins  for polysaccharides 
greatly exceeds their  affinity for monosaccharides.  Such  en- 
hanced  binding  is  due  either  to  a  valency  effect,  in  which 
multiple  sugar  residues  in  the  polysaccharide  can  bind  to 
multiple sites on the lectin (15,  16), or to the presence of specific 
oligosaccharide structures in the polysaccharide with high af- 
finity for the lectin (17). 
We, therefore, examined the effects of a variety of complex 
polysaccharides, of defined composition, on the attachment of 
lymphocytes  to  HEV  (Fig.  7).  Fucoidin,  a  100,000-dalton, 
sulfated polysaccharide consisting predominantly of a  1,2- and 
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a  1,3-1inked  L-fucose (18), proved to be a potent inhibitor (at 
5 #g/m1). A  series of structurally dissimilar, charged polysac- 
charides (19) with equal or greater charge densities (heparin, 
dermatan  sulfate,  dextran  sulfate),  and  equal  or greater size 
~hyaluronic acid) showed no significant  inhibitory activity at 
fivefold higher concentrations. In addition, thyroglobulin, yeast 
mannan, glycogen, horseradish peroxidase, and yeast invertase 
were inactive at 1 mg/ml. 
Fucoidin  was  significantly  more  potent  than  the  active 
monosaccharides with a 0he-half maximal inhibitory activity, 
depending on the experiment, of 1-5 x  10 -8 M  (Fig.  8).  Gel 
filtration analysis (Sephacryl 300, Pharmacia Inc., Piscataway, 
N J) of the commercial fucoidin preparation revealed a minor 
(<10% by weight) protein component.  However, the protein- 
free  polysaccharide  fractions  were  potent  inhibitors  of the 
lymphocyte-HEV binding interaction, indicating that the pro- 
tein was not essential for inhibitory activity (data not shown). 
To determine the target of fucoidin's action, we preincubated 
either frozen sections or the lymphocyte suspensions with 25 
/@/ml of fucoidin, washed them, and then compared them to 
untreated  controls  for binding  activity.  As  shown  in  Fig.  9, 
only  when  lymphocytes  were  pretreated  with  fucoidin  was 
there  residual  inhibitory  activity.  Thus,  fucoidin  acts on  the 
lymphocytes to reduce their affinity for HEV. 
We observed that fucoidin enhanced the clumping of lym- 
phocytes  in  suspension,  in  contrast  to  the  monosaccharide 
inhibitors;  however, this phenomenon  did not appear to cor- 
relate with the degree of inhibitory activity.  Specifically, the 
percentage  of agglutinated  cells  ranged  from  20  to  50%  at 
fucoidin concentrations that decreased lymphocyte attachment 
by 70--100%. Therefore, the random agglutination of a portion 
TABLE  I 
Effect of Monosaccharides and Polysaccharides  on the Rate of 
Protein Synthesis  in Lymphocyte Suspensions 
A 
?g Maximal protein 
Additive *  synthesis:~ 
None (control)§  100 4- 5 
t-Fucose 
150 mM  14 4- 1.5 
75 mM  42 4- 3.3 
D-Fucose 
150 mM  16 4- 2.7 
75 mM  42 +  3.2 
D-Mannose 
150 mM  17 4- 3.3 
D-Galactose 
150 mM  15 +_ 0.04 
B 
Maximal protein 
Additive][  synthesis~. 
None  (control)  100 4- 6 
Fucoidin  66 4- 5 
Heparin  69 _+ 5 
Dextran sulfate  (8 kdaltons)  62 ±  6 
Chondroitin  sulfate  85 4- 5 
* All  solutions contained  leucine-free,  MEM (pH  7.4) supplemented  with  1 
mg/ml  BSA, 60  mM  additional  NaCI,  penicillin,  and  streptomycin  (see 
Materials and Methods) 
I: (Counts in  presence  of additive)  +  (precipitable  counts  in  control)  x  100 
(see Materials and Methods) 
§ 60  mM  NaCl  depressed  protein  synthesis  ~40%  relative to  no-added  salt 
control 
II All  solutions contained  leucine-free,  MEM  (pH  7.4) supplemented  with  I 
mg/ml  BSA, penicillin,  and  streptomycin  and  25  p,g//.tl of  the  specified 
polysaccharide  (see Materials and Methods) of the lymphocyte suspension cannot explain fucoidin's effect. 
However, given the heterogeneity of the lymphocyte suspen- 
sions  we  employ,  it  is  conceivable  that  fucoidin  selectively 
agglutinated those cells capable of binding to HEV. 
Fucoidin does not appear to be selectively toxic for lympho- 
cytes since pre- and post-incubation measurements of trypan 
blue exclusion were identical regardless of the nature  of the 
added polysaccharide. Furthermore, Table I B shows that the 
rate of protein synthesis in the presence  of fucoidin did not 
differ significantly from that in the presence of equal concen- 
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F~GURE 7  Lymphocyte attachment in the presence of various poly- 
saccharides.  Additional  incubation conditions as specified  in  the 
legend of Fig. 2.  CON (no-added-sugar control);  FUC.  (fucoidin); 
HEP. (heparin); C5, (chrondroitin sulfate);  DEXS. (dextran sulfate); 
HA. (hyaluronic acid);  DE/?. 5. (dermatan sulfate). Fucoidin at 5 Fg/ 
ml, all others at 25 #g/ml. Ordinant =  HEV bound cells per HIGH 
power field. Means and SEMs based on four replicates. 
i' 
Ot  '0.O  O.1  1.0  10.0  100.0 
,Ug/ml 
FIGURE 8  Dose-response curves for fucoidin and  heparin. Addi- 
tional incubation conditions as specified  in  the  legend of  Fig. 2. 
Ordinant =  HEV bound cells per HIGH power field. Means and SEMs 
based on three replicates. Control, clear bar.  Fucoidin, stipled bar. 
Heparin, cross-hatched bar. 
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FIGURE 9  Persistent  inhibition of  binding after preincubation of 
lymphocytes with fucoidin. Ordinant: see Materials and  Methods. 
Means  and  SEMs based  on  four  replicates.  {A)  Frozen  sections 
preincubated with fucoidin (25/tg/ml at 7-10°C for 30 min), washed 
(500 ml buffer, 1 dip) and then binding activity compared to frozen 
sections  treated identically except that fucoidin was not present 
during preincubation. Binding assay as specified in  the legend of 
Fig. 2. (B)  Lymphocyte suspension  preincubated with fucoidin (25 
/Lg/ml at 4°C for 30 min), washed by centrifuging through 15 ml of 
buffer (120-fold  dilution of fucoid) and then binding activity com- 
pared  to  lymphocyte suspension  treated  identically except that 
fucoidin was not present during preincubation. Binding assay as 
specified in the legend of Fig. 2. 
trations of several polysaccharides that had no effect on lym- 
phocyte  adhesion.  Taken  together,  these  data  suggest  that 
fucoidin's inhibitory potency cannot be explained  simply on 
the basis of its charge, its molecular size, or a toxic effect. We 
favor  the  hypothesis  that  fucoidin  interacts  with  a  fucose- 
specific lectin on the lymphocyte surface that participates  in 
the attachment of these cells to HEV in vitro. 
DISCUSSION 
Membrane-associated carbohydrate-binding molecules (mem- 
brane lectins) appear to be involved in a variety of physiolog- 
ically significant adhesive interactions (20, 21, 22). The attach- 
ment of certain bacteria and viruses to their host cells appears 
to involve lectins (23, 24). The symbiotic relationship between 
legumes and nitrogen-fixing bacteria is facilitated by the bind- 
ing of bacterial polysaccharides to lectins on the root hairs of 
the plant  host  (25).  The developmentally regulated,  species- 
specific intercellular adhesion of the cellular slime molds Dic- 
tyostelium discoideum and Polysthondylium pallidum appears to 
involve  membrane-bound  lectins  with  affinity  for galactose 
and galactose-containing glycoproteins (26-29). Finally, lectins 
with specificities for fucans have been implicated in the cohe- 
sion of teratocarcinoma stem cells (30, 31), and in the adhesion 
of sperm to egg in the algae Fucus (32), in sea urchins (33), and 
in guinea pigs (34). 
Our present studies indicate that lectins on the lymphocyte 
surface may be involved in the attachment of lymphocytes to 
HEV in vitro and thus contribute to lymphocyte recirculation 
in vivo. Specifically, we f'md that the sulfated,  L-fucose-rich 
polysaccharide fucoidin and the structurally related monosac- 
charides  L-fucose,  D-mannose,  and  a-methyl-D-mamaoside 
(these monosaccharides have an axial 2-hydroxyl and an equa- 
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to HEV in vitro. Furthermore, we have shown that fucoidin 
inhibits binding by acting on the lymphocyte and not the HEV. 
Finally, since inhibition occurs at incubation temperatures of 
7-10°C (temperatures at which the uptake of sugars and mem- 
brane fluidity are, presumably, reduced), we suspect that the 
inhibitors exert their effects at the cell surface. These findings 
are compatible with the hypothesis that lectins on the lympho- 
cyte surface interact with complementary receptors on the HEV 
containing fucose, mannose,  or related carbohydrates (most 
likely as part of protein or lipid-bound oligosaccharides). Ac- 
cording to this view,  the  substances  with inhibitory activity 
would compete with the endogenous receptor for binding sites 
on  the lymphocyte surface,  thereby weakening the adhesive 
interaction between lymphocytes and HEV. Alternatively, the 
inhibitors might produce alterations in the cell shape or affect 
intracellular metabolic processes that secondarily result in de- 
creased adhesiveness. Although we  have  no  direct evidence 
that fucoidin, L-fucose, and D-mannose, compete for the same 
binding site on the lymphocyte surface, there are several ex- 
amples  of cell-surface carbohydrate-binding molecules with 
combined L-fucose/D-mannose (16) or L-fucose/fucoidin spec- 
ificities (34). 
High ionic strength buffers both inhibit the attachment of 
lymphocytes to  HEV  directly and  enhance  the  potency  of 
carbohydrate inhibitors. The fact that high ionic strength alone 
inhibits the adhesive interaction does not diminish the like- 
lihood that a  lectin-carbohydrate interaction is involved. Salt 
solutions can elute specifically  bound carbohydrates from lectin 
affinity columns, suggesting that ionic bonds or salt-sensitive 
tertiary structures  contribute to  the  stability of some lectin- 
carbohydrate interactions (35). Alternative explanations for the 
salt effect include: (a) a salt-sensitive adhesive mechanism that 
is distinct from that involving the putative lectin; (b) metabolic 
inhibition that secondarily affects adhesion; or (c) the quanti- 
tative loss ofionically bound adhesive molecules by salt elution. 
The synergistic effect between NaCI and the specific monosac- 
charide inhibitors may indicate that, as the strength of the salt- 
sensitive bonds diminish, the attraction due to lectin-carbohy- 
drate binding persists and provides the major force holding the 
lymphocytes in place. Regardless of the precise mechanism, 
the hyperionic buffers utilized in our studies dramatically and 
selectively enhance  the inhibitory potencies of L-fucose and 
D-mannose. 
The  sulfated, L-fucose-rich polysaccharide fucoidin shows 
far greater potency on a molar basis than the monosaccharide 
inhibitors. Although its high content of sulfate residues and 
overall size  may  contribute  to  its potency,  other  structural 
characteristics must also be important since structurally dissim- 
ilar  polysaccharides, with  comparable  charge  densities  and 
molecular weights, failed to cause significant inhibition. The 
synergistic effect of NaCI and L-fucose may indicate that both 
lectin-carbohydrate and ionic interactions are involved in the 
attachment of lymphocytes to HEV. If this view is correct, then 
fucoidin's potency may reflect its ability to participate in both 
types of interactions. 
Nearly twenty years have passed since Gesner and Ginsberg 
(36) first suggested that cell-surface carbohydrates play a role 
in the homing of lymphocytes. Our data are compatible with 
the hypothesis that  a  carbohydrate-binding molecule on the 
lymphocyte surface interacts with a  fucose- or mannose-con- 
taining receptor on the postcapillary venule. Since the magni- 
tude of lymphocyte attachment in vitro correlates with the flux 
of circulating ceUs into lymph nodes in vivo, we propose that 
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a  lectin-carbohydrate binding interaction is  involved in  the 
in'st stage of lymphocyte recirculation. 
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